10:40am ET
Health and Healthcare
Just How Expensive Is the Pharmacyclics Buyout?
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
ABBV Coverage Page 44
4:45pm ET
Health and Healthcare
Is Express Scripts 2015 Guidance Good Enough For All-Time Highs?
ThinkstockAfter the markets closed Monday, Express Scripts Holding Company (NASDAQ: ESRX) reported its fourth-quarter financial results as $1.39 in earnings per share (EPS) and $26.31 billion in revenue. This is compared to…
9:05am ET
Health and Healthcare
Jefferies 4 Top Pharmaceutical Stocks to Buy
One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks to buy now according to Jefferies.
8:50am ET
Health and Healthcare
Neurocrine Biosciences Announces New Offering
Neurocrine Biosciences has announced that it will have another public offering of its common stock to raise roughly $225 million.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More
Monday's top analyst upgrades, downgrades and initiations include AbbVie, Alcoa, Apple, Deckers Outdoor, Dish Network, Pfizer and Petrobras.
10:00am ET
Health and Healthcare
Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
12:20pm ET
Health and Healthcare
What to Expect From Gilead Earnings
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
8:55am ET
Health and Healthcare
Are Humira Sales Enough to Lift AbbVie?
AbbVie reported better-than-expected fourth-quarter financial results Friday before the markets open.
Chris Lange 11:00am ET
Health and Healthcare
Gilead Continues to Recover from Express Scripts Loss
Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.
10:45am ET
Health and Healthcare
Is Gilead Already Coming Back Into Favor?
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
12:15pm ET
Health and Healthcare
Analysts Predict Big Value Trap for Gilead Investors
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
1:20pm ET
Health and Healthcare
What the AbbVie and Express Script Deal Means for Gilead
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More
Thursday's top analyst upgrades and downgrades from 24/7 Wall St. include ARIAD Pharmaceuticals, FedEx, Genpact, Suncor Energy, Travelers and UPS.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More
Friday's top analyst upgrades, downgrades and initiations include Harley-Davidson, Lululemon, Nike, SunPower and Walmart.
9:15am ET
Health and Healthcare
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand for the drugs they produce that treat hepatitis C.